8-K: PACS Group Reports Strong First Quarter 2024 Results, Revenue Up 31.9%
Quarterly Report
PACS Group announced a robust first quarter of 2024, with significant increases in revenue, net income, and adjusted EBITDA compared to the same period last year.
Summary
- PACS Group reported a strong first quarter in 2024, with net income reaching $49.1 million, a 30.7% increase year-over-year.
- The company's consolidated GAAP revenue for the quarter was $934.7 million, marking a 31.9% increase compared to the prior year quarter.
- Adjusted EBITDA for the quarter was $88.5 million, a 34% increase year-over-year, while Adjusted EBITDAR reached $152.5 million.
- The company's GAAP earnings per share for the quarter was $0.38, a 31% increase over the prior year quarter.
- Total facility occupancy was 91.1%, with ramping and mature facilities showing occupancy increases of 1.8% and 1.4%, respectively.
- Average Medicare and Medicaid daily rates increased by 11.0% and 5.3%, respectively, compared to the prior year quarter.
- PACS added 10 operating facilities in the quarter, including 1,334 skilled nursing beds and 174 assisted living beds.
- The company added 5,194 beds over the last year, leading to a 35.3% increase in patient days year-over-year.
- PACS now operates 218 facilities and owns 35 properties, with 12 real estate acquisitions in the last 15 months.
- The company is providing full-year 2024 revenue guidance of $3.65 billion to $3.75 billion and adjusted EBITDA guidance of $351 million to $361 million.
Sentiment
Score: 9
Explanation: The document presents a very positive outlook with strong financial results, significant growth, and positive guidance for the future. The company is clearly performing well and is optimistic about its prospects.
Positives
- The company experienced significant growth in revenue, net income, and adjusted EBITDA.
- Occupancy rates remained strong at 91.1% across all facilities.
- The company successfully increased its average Medicare and Medicaid daily rates.
- PACS expanded its operations by adding new facilities and beds.
- The company has a strong CMS Quality Measures rating with 158 facilities having a 4 or 5 star rating.
- The company is actively considering opportunities to acquire both performing and underperforming operations.
- The company has provided positive full year guidance for 2024.
Negatives
- The skilled mix by revenue decreased from 63.7% to 52.0% year-over-year.
- The skilled mix by nursing patient days decreased from 40.3% to 29.8% year-over-year.
- New facilities experienced a decrease in skilled nursing services revenue of 40.8% year-over-year.
- New facilities experienced a decrease in occupancy rate of 7.5% year-over-year.
Risks
- The company is dependent on reimbursement from third-party payors.
- Changes in the acuity mix of patients and payor mix can impact financial results.
- Increased competition for skilled personnel could affect operations.
- Regulatory changes in the healthcare industry could pose challenges.
- The company faces risks related to the expiration of the COVID-19 PHE.
- There are risks associated with the review and audit of care delivery, recordkeeping and billing processes.
- The company faces risks associated with litigation.
- The company relies on information technology.
- There are risks associated with undertaking acquisitions.
- The company relies on payments from third-party payors, including Medicare, Medicaid and other governmental healthcare programs and private insurance organizations.
- The company is subject to various government and third-party payor reviews, auditors and investigations.
- The company is a controlled company.
Future Outlook
PACS is providing full-year 2024 revenue guidance of $3.65 billion to $3.75 billion and adjusted EBITDA guidance of $351 million to $361 million. The company plans to continue its strategy of both leasing and acquiring real estate and is actively considering opportunities to acquire both performing and underperforming operations.
Management Comments
- Jason Murray, PACS's Chief Executive Officer, stated that they are proud of their teams and their dedication to clinical excellence, and they look forward to carrying that momentum through 2024.
- Derick Apt, PACS's Chief Financial Officer, highlighted the strong occupancy rates and the significant increase in patient days due to the addition of new beds.
Industry Context
The announcement reflects a trend of growth and consolidation in the post-acute healthcare sector, with companies like PACS expanding their operations through acquisitions and organic growth. The focus on quality measures and occupancy rates is also consistent with industry trends emphasizing value-based care.
Comparison to Industry Standards
- The 31.9% revenue growth is significantly higher than the average growth rate for the post-acute care industry, which typically sees single-digit growth.
- The occupancy rate of 91.1% is strong compared to the national average for skilled nursing facilities, which often fluctuates between 80-90%.
- The increase in Medicare and Medicaid daily rates is in line with industry trends of increasing reimbursement rates, but the 11% increase in Medicare rates is particularly notable.
- Companies like The Ensign Group (ENSG) and National HealthCare Corporation (NHC) are comparable in the skilled nursing space, but PACS's growth rate appears to be outpacing these competitors in this quarter.
- The company's focus on acquiring both performing and underperforming assets is a common strategy in the industry, similar to that of Omega Healthcare Investors (OHI) in the real estate space.
Stakeholder Impact
- Shareholders will likely view the strong financial results and positive guidance favorably.
- Employees may benefit from the company's growth and expansion.
- Customers (patients and residents) may benefit from the company's focus on clinical excellence and quality measures.
- Suppliers and creditors may see the company as a stable and reliable partner.
Next Steps
- The company will hold a conference call and webcast on May 14, 2024, to discuss the first quarter financial results.
- The company will continue to pursue its strategy of acquiring and leasing real estate.
- The company will continue to consider opportunities to acquire both performing and underperforming operations.
Key Dates
| Date | Description |
|---|---|
| May 13, 2024 | Date of the press release announcing Q1 2024 financial results and the date of the 8-K filing. |
| May 14, 2024 | Date of the conference call and webcast to discuss Q1 2024 financial results. |
| March 31, 2024 | End of the first quarter of 2024, the period for which financial results are reported. |
Keywords
post-acute healthcare, skilled nursing facilities, assisted living, EBITDA, revenue growth, occupancy rates, Medicare, Medicaid, acquisitions, healthcare operations
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.